Clinical Trials Browser

Phase 4 × Pseudomonas Infections × ceftolozane, tazobactam drug combination × Clear all

NCT04673175 2026-01-21

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Phase 4 Terminated

17 enrolled 20 charts

Other hematologic neoplasm

Pneumonia, Pseudomonas Infections, Bacteremia, Gram-Negative Bacterial Infections, Hematologic Neoplasms